{
    "2014-08-11": [
        "RT @SeekingAlpha: Why The Sanofi Deal Is The Best Possible Deal For MannKind Investors $LLY $NVO $SNY $MNKD",
        "$MNKD $SNY MannKind price target raised to $10 from $6.50 at Piper Jaffray",
        "RT @adamfeuerstein: $MNKD Lands Afrezza Partner but at High Cost â€”> $SNY",
        "$RXDX $SNY Ignyta names Adrian Senderowicz as Chief Medical Officer",
        "RT @JacobEPVantage: $MNKD says $SNY's &lt;$175m advance is structured as a 10-year loan facility at 8.5% per annum"
    ]
}